S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Undervalued UnitedHealth Group Won’t Be For Long
3 Computer Vision Stocks for Long-Term Gains From AI
DocuSign and The Case for 66% Upside 
Closing prices for crude oil, gold and other commodities
NASDAQ:IOSP

Innospec (IOSP) Stock Price, News & Analysis

$120.97
-0.82 (-0.67%)
(As of 04/16/2024 ET)
Today's Range
$120.22
$121.61
50-Day Range
$116.41
$129.55
52-Week Range
$91.74
$131.18
Volume
50,114 shs
Average Volume
89,866 shs
Market Capitalization
$3.02 billion
P/E Ratio
21.72
Dividend Yield
1.19%
Price Target
N/A

Innospec MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.89% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
1.20mentions of Innospec in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$4.53 M Sold Last Quarter
Proj. Earnings Growth
9.23%
From $6.72 to $7.34 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.25 out of 5 stars

Basic Materials Sector

29th out of 169 stocks

Chemicals & Allied Products Industry

5th out of 13 stocks

IOSP stock logo

About Innospec Stock (NASDAQ:IOSP)

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels. This segment's products are used in the operation of commercial trucking, marine and aviation engines, power station generators, heating oil, and other industrial machinery applications. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, construction, mining, and other industrial markets. The company's Oilfield Services segment develops and markets chemical solutions for drilling, completion, fracturing, stimulation, and completion operations; and products for oil and gas production. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.

IOSP Stock Price History

IOSP Stock News Headlines

The Returns At Innospec (NASDAQ:IOSP) Aren't Growing
Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
Innospec Inc.
Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
Q2 2021 Innospec Inc Earnings Call Transcript
Q3 2021 Innospec Inc Earnings Call Transcript
Q4 2021 Innospec Inc Earnings Call Transcript
Q1 2022 Innospec Inc Earnings Call Transcript
Q2 2022 Innospec Inc Earnings Call Transcript
Q3 2022 Innospec Inc Earnings Call Transcript
Q4 2022 Innospec Inc Earnings Call Transcript
Q1 2023 Innospec Inc Earnings Call Transcript
Q2 2023 Innospec Inc Earnings Call Transcript
Q3 2023 Innospec Inc Earnings Call Transcript
Innospec Inc CEO Patrick Williams Sells Company Shares
Innospec Inc CEO Patrick Williams Sells 9,667 Shares
IOSP Feb 2024 105.000 call
See More Headlines
Receive IOSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innospec and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/13/2024
Today
4/16/2024
Next Earnings (Confirmed)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
Specialty Chemicals
Current Symbol
NASDAQ:IOSP
CUSIP
45768S10
Employees
2,400
Year Founded
1938

Profitability

Net Income
$139.10 million
Pretax Margin
8.95%

Debt

Sales & Book Value

Annual Sales
$1.95 billion
Cash Flow
$7.58 per share
Book Value
$46.23 per share

Miscellaneous

Free Float
24,610,000
Market Cap
$3.01 billion
Optionable
Optionable
Beta
1.10

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Patrick S. WilliamsMr. Patrick S. Williams (Age 59)
    President, CEO & Director
    Comp: $3.94M
  • Mr. Ian Philip Cleminson (Age 59)
    Executive VP & CFO
    Comp: $1.09M
  • Dr. Philip J. Boon (Age 65)
    COO & Executive VP
    Comp: $955.19k
  • Dr. Ian M. McRobbie (Age 75)
    Chief Technology Officer and Senior VP of Research & Technology
    Comp: $745.37k
  • Mr. David Bentley Jones (Age 54)
    Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary
    Comp: $846.46k
  • Mr. Graeme Blair (Age 41)
    Head of Group Finance
  • Dr. Corbin Barnes (Age 51)
    Senior Vice President of Corporate Development & Investor Relations
  • Mr. Trey Griffin (Age 58)
    Senior Vice President of Human Resources
  • Mr. Thomas C. Entwistle
    President of Oilfield Services - Americas
  • Mr. Steven W. Williams (Age 68)
    Executive Director

IOSP Stock Analysis - Frequently Asked Questions

How have IOSP shares performed in 2024?

Innospec's stock was trading at $123.24 on January 1st, 2024. Since then, IOSP stock has decreased by 1.7% and is now trading at $121.10.
View the best growth stocks for 2024 here
.

Are investors shorting Innospec?

Innospec saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 218,800 shares, a decline of 20.1% from the March 15th total of 273,800 shares. Based on an average daily trading volume, of 90,400 shares, the days-to-cover ratio is presently 2.4 days. Currently, 0.9% of the company's shares are short sold.
View Innospec's Short Interest
.

When is Innospec's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our IOSP earnings forecast
.

How can I listen to Innospec's earnings call?

Innospec will be holding an earnings conference call on Friday, May 10th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) posted its earnings results on Tuesday, February, 13th. The specialty chemicals company reported $1.84 EPS for the quarter, topping the consensus estimate of $1.59 by $0.25. The specialty chemicals company had revenue of $494.70 million for the quarter, compared to analysts' expectations of $479.47 million. Innospec had a net margin of 7.14% and a trailing twelve-month return on equity of 13.69%. Innospec's quarterly revenue was down 3.1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.20 earnings per share.

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec announced a Semi-Annual dividend on Monday, November 6th. Shareholders of record on Monday, November 20th will be given a dividend of $0.72 per share on Monday, November 27th. This represents a dividend yield of 1.4%. The ex-dividend date is Friday, November 17th. This is a boost from the stock's previous Semi-Annual dividend of $0.69.
Read our dividend analysis for IOSP
.

Is Innospec a good dividend stock?

Innospec (NASDAQ:IOSP) pays an annual dividend of $1.44 per share and currently has a dividend yield of 1.17%. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 25.85%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, IOSP will have a dividend payout ratio of 19.62% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for IOSP.

What is Patrick S. Williams' approval rating as Innospec's CEO?

12 employees have rated Innospec Chief Executive Officer Patrick S. Williams on Glassdoor.com. Patrick S. Williams has an approval rating of 96% among the company's employees. This puts Patrick S. Williams in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Innospec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include NVIDIA (NVDA), Altria Group (MO), Ecolab (ECL), Eastman Chemical (EMN), Corning (GLW), Realty Income (O), Pfizer (PFE), Sherwin-Williams (SHW), Weyerhaeuser (WY) and Applied Materials (AMAT).

Who are Innospec's major shareholders?

Innospec's stock is owned by a number of institutional and retail investors. Top institutional investors include First Hawaiian Bank (0.03%), Ballentine Partners LLC (0.02%) and Los Angeles Capital Management LLC (0.01%). Insiders that own company stock include Brian Watt, Claudia Poccia, Corbin Barnes, David B Jones, David Landless, Hardy Louis Griffin III, Ian Cleminson, Ian Malcolm Mcrobbie, Ian Malcolm Mcrobbie, Larry Padfield, Leslie J Parrette, Milton C Blackmore, Patrick Williams and Philip John Boon.
View institutional ownership trends
.

How do I buy shares of Innospec?

Shares of IOSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:IOSP) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners